Rani Therapeutics Holdings CEO Talat Imran's 2023 pay jumps 22% to $5.3M
Rani Therapeutics Holdings reports 2023 executive compensation
By ExecPay News
Published: April 17, 2024
Rani Therapeutics Holdings reported fiscal year 2023 executive compensation information on April 17, 2024.
In 2023, three executives at Rani Therapeutics Holdings received on average a compensation package of $3.2M, a 11% increase compared to previous year.
Average pay of disclosed executives at Rani Therapeutics Holdings
Talat Imran, Chief Executive Officer, received $5.3M in total, which increased by 22% compared to 2022. 55% of Imran's compensation, or $2.9M, was in option awards. Imran also received $450K in salary and $1.9M in stock awards.
Mir Hashim, Chief Scientific Officer, received a compensation package of $2.2M, which decreased by 7% compared to previous year. 46% of the compensation package, or $996K, was in option awards.
Svai Sanford, Chief Financial Officer, earned $2.2M in 2023, a 9% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 17, 2024.